CAS 1217474-40-2

NAS-181

CAS : 1217474-40-2

NAS-181 is a drug that inhibits the voltage-dependent calcium channels. It has been shown to be effective in reducing pain and inflammation from chronic headaches. NAS-181 is a non-selective antagonist of 5-HT1A and 5-HT1B receptors, which are both linked to the transmission of pain signals from the central nervous system. NAS-181 also affects neurotransmission by inhibiting glutamate release in the brain and monoamine neurotransmitters such as dopamine. This drug has been shown to inhibit neuronal activity in the mouse striatum, an area associated with motor control, cognition, and mood regulation.
br>br>
This drug is being developed for the treatment of migraine headaches.br>br>

Formule : C₂₁H₃₄N₂O₁₀S₂

Degré de pureté : Min. 95%

Masse moléculaire : 538.6 g/mol

Ref: 3D-SYB47440

NAS181

CAS : 1217474-40-2

rat 5-HT1B receptor antagonist

Formule : C₂₁H₃₄N₂O₁₀S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 538.63

Ref: TM-T23055